Mettler-Toledo International Inc. (MTD) Stock Forecast
Data as of Aug 1, 2026Healthcare · Current price $1427.46 (+3.32%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 9, 2026 | Kallum Titchmarsh | Morgan Stanley | $1475.00 | +3.3% |
| Feb 9, 2026 | Catherine Ramsey Schulte | Robert W. Baird | $1445.00 | +1.2% |
| Dec 1, 2025 | Kallum Titchmarsh | Morgan Stanley | $1550.00 | +8.6% |
| May 19, 2025 | Dan Leonard | UBS | $1350.00 | -5.4% |
| May 4, 2025 | Tycho Peterson | Jefferies | $1100.00 | -22.9% |
| Nov 11, 2024 | Daniel Arias | Stifel Nicolaus | $1450.00 | +1.6% |
| Aug 5, 2024 | Daniel Arias | Stifel Nicolaus | $1550.00 | +8.6% |
| Aug 5, 2024 | Catherine Schulte | Robert W. Baird | $1375.00 | -3.7% |
| Jun 3, 2024 | Tycho Peterson | Jefferies | $1250.00 | -12.4% |
| May 13, 2024 | Daniel Arias | Stifel Nicolaus | $1510.00 | +5.8% |
| May 13, 2024 | Catherine Schulte | Robert W. Baird | $1360.00 | -4.7% |
| Sep 6, 2022 | Daniel Arias | Stifel Nicolaus | $1500.00 | +5.1% |
| Jul 31, 2022 | Elizabeth Garcia | UBS | $1237.00 | -13.3% |
Top Analysts Covering MTD
MTD vs Sector & Market
| Metric | MTD | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.36 | 2.25 | 2.42 |
| Analyst Count | 11 | 8 | 19 |
| Target Upside | +4.1% | +16366.1% | +18.0% |
| P/E Ratio | 33.42 | 2.98 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4.20B | $4.23B | $4.25B | 10 |
| 2027-03-31 | $980M | $984M | $994M | 4 |
| 2027-06-30 | $1.08B | $1.09B | $1.10B | 3 |
| 2027-09-30 | $1.12B | $1.13B | $1.14B | 3 |
| 2027-12-31 | $1.24B | $1.24B | $1.26B | 3 |
| 2028-03-31 | $1.03B | $1.03B | $1.04B | 2 |
| 2028-06-30 | $1.15B | $1.15B | $1.17B | 5 |
| 2028-09-30 | $1.19B | $1.20B | $1.21B | 4 |
| 2028-12-31 | $1.32B | $1.32B | $1.34B | 4 |
| 2029-12-31 | $4.89B | $4.93B | $4.96B | 5 |
| 2030-12-31 | $5.08B | $5.13B | $5.16B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $46.36 | $46.50 | $46.63 | 8 |
| 2027-03-31 | $9.88 | $9.93 | $10.07 | 3 |
| 2027-06-30 | $12.10 | $12.15 | $12.32 | 2 |
| 2027-09-30 | $13.20 | $13.26 | $13.44 | 2 |
| 2027-12-31 | $15.77 | $15.84 | $16.06 | 2 |
| 2028-03-31 | $11.43 | $11.49 | $11.65 | 3 |
| 2028-06-30 | $13.76 | $13.82 | $14.01 | 6 |
| 2028-09-30 | $14.81 | $14.87 | $15.08 | 5 |
| 2028-12-31 | $17.06 | $17.14 | $17.38 | 5 |
| 2029-12-31 | $61.99 | $62.66 | $63.15 | 1 |
| 2030-12-31 | $67.73 | $68.47 | $69.00 | 1 |
Frequently Asked Questions
What is the analyst consensus for MTD?
The consensus among 11 analysts covering Mettler-Toledo International Inc. (MTD) is Buy with an average price target of $1392.25.
What is the highest price target for MTD?
The highest price target for MTD is $1550.00, set by Kallum Titchmarsh at Morgan Stanley on 2025-12-01.
What is the lowest price target for MTD?
The lowest price target for MTD is $1100.00, set by Tycho Peterson at Jefferies on 2025-05-04.
How many analysts cover MTD?
11 analysts have issued ratings for Mettler-Toledo International Inc. in the past 12 months.
Is MTD a buy or sell right now?
Based on 11 analyst ratings, MTD has a consensus rating of Buy (2.36/5) with a +4.1% upside to the consensus target of $1392.25.
What are the earnings estimates for MTD?
Analysts estimate MTD will report EPS of $46.50 for the period ending 2026-12-31, with revenue estimated at $4.23B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.